Aytu Biopharma (AYTU) Operating Income Growth (3y) (2014 - 2026)
Aytu Biopharma (AYTU) Operating Income Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.97 Bn | 87.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 32.26 Bn | 30.32 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.15 Bn | 21.00 Bn | 648.10 Mn | 4.63% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.86 Bn | 16.55 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | 40.17% |
| 10 | Aytu Biopharma | 23.13 Mn | -3.59 Mn | 7.60 Mn | 21.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.98% |
| Dec 31, 2025 | 34.05% |
| Sep 30, 2025 | 5.95% |
| Jun 30, 2025 | 23.37% |
| Mar 31, 2025 | 26.94% |
| Dec 31, 2024 | 46.86% |
| Sep 30, 2024 | 67.74% |
| Jun 30, 2024 | 54.46% |
| Dec 31, 2023 | 36.87% |
| Sep 30, 2023 | 37.53% |
| Jun 30, 2023 | 26.52% |
| Mar 31, 2023 | -21.31% |
| Dec 31, 2022 | -11.41% |
| Sep 30, 2022 | 27.45% |
| Jun 30, 2022 | -54.65% |
| Mar 31, 2022 | -131.63% |
| Dec 31, 2021 | -35.39% |
| Sep 30, 2021 | -100.88% |
| Jun 30, 2021 | -84.60% |
| Dec 31, 2020 | -11.76% |